A patient with a complex medical history was implanted with a 15mm amplatzer septal occluder (aso) on (b)(6) 2015 secondary to increasing dyspnea and hypoxemia.Pre-implant, the defect was balloon-sized to 14mm before "stop flow" was achieved.Follow-up echo on (b)(6) 2015, looked satisfactory.On (b)(6) the patient presented to the emergency room with presyncopal episodes and tachycardia at which point a ct diagnosed a pericardial effusion.The patient was transferred to (b)(6) where a tte confirmed the effusion and the patient was sent to surgery.Cardiac tamponade was present and pericardiocentesis was performed with approximately 200ml of sanguineous fluid removed.The aso was explanted and the erosion to the atrial roof was repaired, along with a patch closure asd was performed.
|
(b)(4).The results of this investigation concluded the aso was covered in a mucus-like material that made gross, dimensional, and functional analysis difficult.A review of the device history record confirmed the occluder met all visual, dimensional, and functional specifications at the time it was manufactured, prior to shipment.There was no evidence to suggest there was an intrinsic defect, as supported by review of the valve's device history record.The cause of the reported event remains unknown.The event was reviewed by the sjm erosion board who confirmed that erosion occurred.
|